3MY0
Crystal structure of the ACVRL1 (ALK1) kinase domain bound to LDN-193189
3MY0 の概要
エントリーDOI | 10.2210/pdb3my0/pdb |
分子名称 | Serine/threonine-protein kinase receptor R3, 4-[6-(4-piperazin-1-ylphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline (3 entities in total) |
機能のキーワード | protein kinase, serine/threonine-protein kinase receptor, structural genomics, structural genomics consortium, sgc, transferase |
由来する生物種 | Homo sapiens (human) |
細胞内の位置 | Membrane; Single-pass type I membrane protein: P37023 |
タンパク質・核酸の鎖数 | 24 |
化学式量合計 | 845164.82 |
構造登録者 | Chaikuad, A.,Alfano, I.,Cooper, C.,Mahajan, P.,Daga, N.,Sanvitale, C.,Fedorov, O.,Petrie, K.,Savitsky, P.,Gileadi, O.,Sethi, R.,Krojer, T.,Muniz, J.R.C.,Pike, A.C.W.,Vollmar, M.,Carpenter, C.P.,Ugochukwu, E.,Knapp, S.,von Delft, F.,Weigelt, J.,Arrowsmith, C.H.,Edwards, A.M.,Bountra, C.,Bullock, A.,Structural Genomics Consortium (SGC) (登録日: 2010-05-08, 公開日: 2010-07-21, 最終更新日: 2023-11-01) |
主引用文献 | Kerr, G.,Sheldon, H.,Chaikuad, A.,Alfano, I.,von Delft, F.,Bullock, A.N.,Harris, A.L. A small molecule targeting ALK1 prevents Notch cooperativity and inhibits functional angiogenesis. Angiogenesis, 18:209-217, 2015 Cited by PubMed Abstract: Activin receptor-like kinase 1 (ALK1, encoded by the gene ACVRL1) is a type I BMP/TGF-β receptor that mediates signalling in endothelial cells via phosphorylation of SMAD1/5/8. During angiogenesis, sprouting endothelial cells specialise into tip cells and stalk cells. ALK1 synergises with Notch in stalk cells to induce expression of the Notch targets HEY1 and HEY2 and thereby represses tip cell formation and angiogenic sprouting. The ALK1-Fc soluble protein fusion has entered clinic trials as a therapeutic strategy to sequester the high-affinity extracellular ligand BMP9. Here, we determined the crystal structure of the ALK1 intracellular kinase domain and explored the effects of a small molecule kinase inhibitor K02288 on angiogenesis. K02288 inhibited BMP9-induced phosphorylation of SMAD1/5/8 in human umbilical vein endothelial cells to reduce both the SMAD and the Notch-dependent transcriptional responses. In endothelial sprouting assays, K02288 treatment induced a hypersprouting phenotype reminiscent of Notch inhibition. Furthermore, K02288 caused dysfunctional vessel formation in a chick chorioallantoic membrane assay of angiogenesis. Such activity may be advantageous for small molecule inhibitors currently in preclinical development for specific BMP gain of function conditions, including diffuse intrinsic pontine glioma and fibrodysplasia ossificans progressiva, as well as more generally for other applications in tumour biology. PubMed: 25557927DOI: 10.1007/s10456-014-9457-y 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.65 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード